NASDAQ:RYTM | Free Cash Flow | RHYTHM PHARMACEUTICALS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$44.19M
2025-12-31-$25.39M
2025-03-31-$40.35M
2024-12-31-$18.85M
2024-03-31-$40.74M
2023-12-31-$29.38M-$1,000.00-$29.38M
2023-03-31-$36.43M$47,000.00-$36.48M
2022-12-31-$34M-$1,000.00-$34M
2022-03-31-$53.63M$127,000.00-$53.76M
2021-12-31-$40.47M$68,000.00-$40.54M
2021-03-31-$33.53M$12,000.00-$33.54M-76.67%
2020-12-31-$29.12M$84,000.00-$29.21M
2020-03-31-$36.1M
2019-12-31-$32.22M$0.00-$32.22M
2019-03-31-$31.38M$811,000.00-$32.19M
2018-12-31-$20.98M$395,000.00-$21.38M
2018-03-31-$11.65M
2017-12-31-$7.89M$55,000.00-$7.94M
2017-03-31-$7.02M
2016-12-31-$6.18M$0.00-$6.18M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$115.68M$953,000.00-$116.63M
2024-12-31-$113.88M$0.00-$113.88M
2023-12-31-$136.16M$47,000.00-$136.2M
2022-12-31-$173.43M$281,000.00-$173.71M
2021-12-31-$146M$434,000.00-$146.44M
2020-12-31-$121.98M$214,000.00-$122.19M
2019-12-31-$122.75M$3.39M-$126.14M
2018-12-31-$62.06M$722,000.00-$62.78M
2017-12-31-$29.46M$133,000.00-$29.59M
2016-12-31-$23.22M$1.06M-$24.28M
2015-12-31-$6.98M$17,000.00-$6.99M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.